Ealixir Stock

Ealixir Revenue

The The revenue of Ealixir (EAXR) as of Aug 16, 2026 is 3.53 M USD.

Revenue

3.53 MUSD

Last updated:

In 2026, Ealixir's sales reached 3.53 M USD, a % difference from the 0.00 USD sales recorded in the previous year.

Over the last 14 years Ealixir grew revenue by 9.7% annually, reaching 3.53 M USD.

The Ealixir Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

REVENUE (M USD)
GROSS MARGIN (%)
Date
REVENUE (M USD)
GROSS MARGIN (%)
Jan 1, 2007
0.97 base
93.69 base
Jan 1, 2008
3.15 base
-27.84 base
Jan 1, 2009
34.34 base
-1.92 base
Jan 1, 2010
34.06 base
4.59 base
Jan 1, 2011
15.79 base
3.37 base
Jan 1, 2012
10.75 base
6.81 base
Jan 1, 2020
0.00 base
0.00 base
Jan 1, 2021
3.53 base
75.64 base
YEARREVENUE (M USD)GROSS MARGIN (%)
2021 3.5375.64
2020 --
2012 10.756.81
2011 15.793.37
2010 34.064.59
2009 34.34-1.92
2008 3.15-27.84
2007 0.9793.69
Access this data via the Eulerpool API

Ealixir Revenue

Ealixir Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2007
966,000.00 USD
-989,000.00 USD
-2.12 M USD
Jan 1, 2008
3.15 M USD
-3.54 M USD
-3.86 M USD
Jan 1, 2009
34.34 M USD
-10.79 M USD
-14.56 M USD
Jan 1, 2010
34.06 M USD
-6.71 M USD
-28.87 M USD
Jan 1, 2011
15.79 M USD
-4.74 M USD
-10.66 M USD
Jan 1, 2012
10.75 M USD
-1.48 M USD
-307,000.00 USD
Jan 1, 2020
0.00 USD
-447,000.00 USD
-631,000.00 USD
Jan 1, 2021
3.53 M USD
0.00 USD
124,000.00 USD

Ealixir Margins

Ealixir stock margins

The Ealixir margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Ealixir. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Ealixir.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2007
93.69 %
-102.38 %
-219.46 %
Jan 1, 2008
-27.84 %
-112.43 %
-122.70 %
Jan 1, 2009
-1.92 %
-31.41 %
-42.41 %
Jan 1, 2010
4.59 %
-19.69 %
-84.75 %
Jan 1, 2011
3.37 %
-30.04 %
-67.54 %
Jan 1, 2012
6.81 %
-13.75 %
-2.86 %
Jan 1, 2020
75.64 %
- %
- %
Jan 1, 2021
75.64 %
0.00 %
3.51 %

Ealixir Stock analysis

What does Ealixir do? Ealixir Inc is a biotechnology company founded in 2012 by Dr. Nithin Rajan. Dr. Rajan earned his doctoral degree in biomedical science from the University of Ottawa and has over ten years of experience in the field of biomedical research. Ealixir Inc is an innovative firm specializing in the development of novel therapeutic technologies based on cell and proteomic research. Ealixir's goal is to help patients with serious or chronic illnesses by offering biological solutions that support the body's natural functions. Ealixir has developed the concept of "lifestyle medicine," aiming to develop treatments that not only combat diseases but also influence the patient's lifestyle to help them lead a healthier life. The company follows an integrative approach, combining the use of medications and other therapeutic approaches. Ealixir specializes in ingredients and technologies that have the potential to stimulate and activate the body to promote natural regenerative processes. One of Ealixir's significant products is the Arthritin system, which is used for the treatment of arthritis and pain. Arthritin utilizes a blend of pain relief, inflammation inhibitors, and regeneration promoters to effectively alleviate arthritis pain and reverse the damage caused by the disease to the joints. Ealixir is also a pioneer in the development of nano "in-minutes" technologies, where nanoparticles are used to actively transport active substances to specific target cells, thereby achieving results in minutes rather than hours. Another important product of Ealixir is Collagenix, a beauty product that uses a blend of collagen, vitamins, and minerals to improve skin structure and wrinkle depth. Ealixir also offers products for animal care and medicine. The company has developed a new product for wound care in pets using the Ealixir technology. The solution consists of antibacterial ingredients and promotes the growth of new tissue. Ealixir also focuses on researching dietary supplements that contribute to overall health and well-being. The company pays special attention to proteins, magnesium, and omega-3 fatty acids. The range includes CBD oil and support for restful sleep. Overall, Ealixir has established itself as a leading company in biomedical research and the development of innovative therapies. The company's products are at the forefront of technology and are developed and tested by a great team of researchers and scientists. The brand has experienced rapid growth in recent years and will undoubtedly achieve many successes in the future, benefiting both patients and animal lovers as well as people who value health and wellness. Ealixir is one of the most popular companies on Eulerpool.

Revenue Details

Understanding Ealixir's Sales Figures

The sales figures of Ealixir originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Ealixir’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Ealixir's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Ealixir’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Ealixir stock

The revenue of Ealixir is 3.53 M USD in 2026.

On Eulerpool you can find the complete historical development of The revenue Ealixir since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's Ealixir historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Ealixir

All Key Metrics — Ealixir